Navigation Links
Neuro Kinetics Appoints Dr. Terri Ives Clinical Director, Audiology

PITTSBURGH, Dec. 3 /PRNewswire/ -- Neuro Kinetics, Inc. (, manufacturers of noninvasive medical diagnostic equipment used worldwide for balance, vestibular and neurological disorder tests, said today that Dr. Terri Ives has been appointed clinical director, audiology.

Ives will manage the company's clinical testing, coordination of multi- site research projects, clinical support, regulatory compliance and educational/training outreach programs for audiologists and other specialists. She also will be involved in new product development and research and will help represent the company with professional associations.

Earlier this year, Neuro Kinetics introduced its I-Portal(R)-VNG (Video Nystagmography System) and I-Portal(R)-Super VNG, designed for in-office early-screening balance and dizziness testing by audiologists, as well as otolaryngologists, neurologists and others. The company also manufactures other medical devices, including the Neuro-Otologic Test Center (NOTC) featuring its renowned barany (rotational) chair.

"We are delighted that Dr. Ives has opted to continue her distinguished career with our company," Howison Schroeder, Neuro Kinetics president and CEO, said. "Terri brings a tremendous depth of knowledge and expertise about audiology and diagnosis of disorders related to it. She also has a rare combination of perspectives from her work as a clinician, researcher, instructor, and executive in both academia and the medical equipment field. Terri will play a significant role for our company as we continue to expand our presence in the audiology market."

Said Ives, "I am excited by the opportunity to work with the highly skilled team at Neuro Kinetics. This company is on the move forward with amazing technological advances and I'm thrilled to be part of it."

Before joining Neuro Kinetics, Ives held a number of managerial and research positions at clinics, research facilities and medical firms. She was manager of clinical research at Sound ID in Palo Alto, California, and also was chief of audiology and director of the Balance Center at the Hearing Institute for Children and Adults in San Jose, California.

Ives also was director of diagnostic audiology at the California Ear Institute at Stanford in Palo Alto. She has served on various editorial, advisory and examination boards for such leading publications as Audiology Online and the American Academy of Audiology Vestibular Disorders Evaluation and Treatment Examination Committee.

A Fellow in the American Academy of Audiology and holding the Certificate of Clinical Competence in Audiology (CCC-A) by the American Speech-Language- Hearing Association, Ives has a Doctor of Audiology degree from the Pennsylvania College of Optometry's School of Audiology (where she also served as an assistant professor), both a Doctor of Science in Audiology and a Master of Audiology from Boston University, and a Bachelor of Science in Communication Disorders from Emerson College (with honors).

Ives, originally born in Cheyenne, Wyoming, and raised on the family homestead ranch near Rozet, Wyoming, now lives in the Denver area. Her husband, Phillip Ives, Au.D., is the manager of issue tracking with Advanced Bionics Corporation. They have four children.

For more information about Neuro Kinetics, please visit its Web site ( or contact the company in the U.S. +1.412.963.6649 or via e-mail to


John Buckman

Buckman Communications, for Neuro-Kinetics, Inc.

+ 1 412-381-2900 or

SOURCE Neuro Kinetics, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Study suggests loss of 2 types of neurons -- not just 1 -- triggers Parkinsons symptoms
2. New research shows how chronic stress worsens neurodegenerative disease course
3. NYU study points to lasting impact of mild hearing loss on neurological processes
4. Low level of neuronal receptor linked to mild cognitive impairment and Alzheimers disease
5. Special Conference: Women and Neurological Diseases
6. Neurobiological Technologies Reports Going Concern Qualification
7. Brandeis neuroscientist wins NIH directors Pioneer Award
8. Deane F. Johnson Center for Neurotherapeutics to Launch First Mobile Medical Unit on October 4th
9. Kids Vaccine Ingredient Not Likely Linked to Neurological Problems
10. Loss of gene leads to protein splicing and buildup of toxic proteins in neurons
11. Neurobiological Technologies, Inc. Announces Receipt of Determination Letter from NASDAQ
Post Your Comments:
(Date:11/25/2015)... BROOK, Ill. (PRWEB) , ... November 25, 2015 ... ... larger and potentially more aggressive than those found on mammography, according to a ... MRI findings of additional cancers not seen on mammography may necessitate a change ...
(Date:11/25/2015)... ... 2015 , ... As part of a global movement to ... together who want to combine talents and resources to help create sustainable communities ... The non-profit launched its first major fundraiser on November 6, 2015 at Bent ...
(Date:11/25/2015)... ... November 25, 2015 , ... The holiday season ... and pleasing the palates of attendees is of the utmost importance. Whether you ... seasonal get-together, give these recipes a try this holiday season. , Turkey Croquettes ...
(Date:11/25/2015)... ... November 25, 2015 , ... Finnleo, a leader in ... on several models of traditional and far-infrared saunas. , For traditional saunas, ... the most traditional Finnish sauna wood, and Finnleo uses only European Grade A Nordic ...
(Date:11/25/2015)... , ... November 25, 2015 , ... ... has been recognized once again for its stellar workplace culture with the company’s ... , Medical Solutions’ Cincinnati office was named a finalist in Cincinnati ...
Breaking Medicine News(10 mins):
(Date:11/25/2015)... ) ... "Global Brain Monitoring Devices Market 2015-2019" ... ) has announced the addition of ... 2015-2019" report to their offering. ... ) has announced the addition of the ...
(Date:11/25/2015)... -- The total global healthcare industry is expected to grow at ... America has the highest projected growth at 12.7%, ... ), is second with growth projected at 11.5%. ... expenditure. In 2013-2014, total government funded healthcare was nearly 68%. ... 41.2% in 2013-2014. In real terms, out of pocket expenditure ...
(Date:11/25/2015)... Nov. 25, 2015  Amgen (NASDAQ: AMGN ) ... (BLA) with the United States ... a biosimilar candidate to Humira ® (adalimumab). Amgen ... submitted to the FDA and represents Amgen,s first BLA ... E. Harper , M.D., executive vice president of Research ...
Breaking Medicine Technology: